Atossa Therapeutics, Inc. Common Stock ATOS
$2.45
+2.08%
at last close
Financials (TTM)
- Revenue
- —
- Net Income
- $-37,709,000
- Net Margin
- —
- Return on Equity
- -140.55%
- Debt-to-Equity
- —
- P/E Ratio
- —
- Price / Book
- 0.89
- Price / Sales
- —
Over the trailing twelve months, Atossa Therapeutics, Inc. Common Stock generated revenue of — and net income of $-37,709,000.
Key Stats
- Last Close
- $2.45
- Market Cap
- $23.95 million
- 52-Week Range
- $1.70 – $19.35
- Average Volume
- 56K shs
Data is delayed and provided for informational purposes only. Not investment advice. See our disclaimer.